ehealth radio network
Going the Extra Mile: Central Ohio Primary Care Physicians Launches Vaccine “Delivery Service” to Provide Shots to Homebound Patients

Going the Extra Mile: Central Ohio Primary Care Physicians Launches Vaccine “Delivery Service” to Provide Shots to Homebound Patients

August 12, 2021

 

shawn_ameraf1li.jpeg

 

Shawn Amer, Clinical Program Director at Central Ohio Primary Care with more than 70 practices serving over 400,000 patients and the largest independent primary care group in the country joins eHealth Radio and the Health Care and Health News Channels.


Listen to interview with host Eric Michaels and guest Shawn Amer discuss the following:

  1. I understand that during the vaccine rollout, Central Ohio Primary Care launched a vaccine “delivery service” to vaccinate homebound patients. Can you tell us more about this initiative? Why did COPC launch this program?
  2. What are some of the hurdles you have encountered in vaccinating home-bound seniors? What success have you seen through this program?
  3. How has this program been meaningful to you and your team at Central Ohio Primary Care? Is there a patient experience that was particularly memorable?
  4. I understand that COPC has launched other initiatives for senior patients during the pandemic to make healthcare more accessible. Can you tell us more about these efforts?
  5. What are the benefits to Senior Access? Who is eligible for the program?

Shawn Amer joined Central Ohio Primary Care as Clinical Program Director in 2019. A graduate of Ohio State University, Shawn has held various directorial and management positions at healthcare organizations throughout the Midwest. During the COVID-19 pandemic, Shawn was a driving force in the creation of COPC’s vaccine “delivery service,” a new program that has been successful in vaccinating Columbus’ most vulnerable population: home-bound seniors.

 

2019_BFPC-Linear-new_logo28xgiy.png

 

Website: https://www.copcp.com

Social Media Links:
Facebook: facebook.com/CentralOhioPrimaryCare
Linkedin: linkedin.com/company/central-ohio-primary-care-physicians

New Charitable App Promotes “Active Aging”

New Charitable App Promotes “Active Aging”

August 10, 2021

 

Joe_Liu_2bi7kk.jpg

 

Joe Liu, Founder of the Joe & Emmy Liu Charitable Foundation and developer of Lively Health, the first charitable self-directed lifestyle conditioning App for prevention of chronic conditions and active aging joins eHealth Radio and the Health News and Technology Channels.


Listen to interview with host Eric Michaels and guest Joe Liu discuss the following:

  1. What was the impetus behind the creation of the Lively Health app?
  2. What separates Lively Health from all the other “wellness” apps on the market?
  3. You say your app promotes the concept of “active aging.” Can you explain exactly what that is and why it’s important?
  4. It’s been proven that people in lower socioeconomic groups have less access to quality health care and are more susceptible to chronic medical conditions? Is that why you made the app free for download?
  5. Your app takes a very holistic approach, asking the user to not only answer questions about their physical health but also their social, financial and psychological status. Do you feel that the medical establishment doesn’t place enough emphasis on these so-called “peripheral” areas when evaluating a person’s overall health?

Joe Liu is a Silicon Valley serial entrepreneur, who started the Joe & Emmy Liu Foundation with a vision to benefit humanity with his entrepreneurial and technical expertise. Liu started his first company Techlink Co. in 1984. He then co-founded Oplink Communications in 1995, led the IPO in 2000, and acquisition by Molex/Koch Industries in 2014. Liu angel invested in numerous high-tech companies, guided them to successful exits, and contributed tremendously to the growth of IT industry. Joe and his wife Emmy started The Joe and Emmy Liu Family Foundation in 2019, as a 501(c)3 private operating foundation using technology innovation to benefit human well-being.

 

Lively_Health_logoawkvw.png

 

Website: https://livelyhealth.org

Social Media Links:
Facebook: facebook.com/Livelyhealthfoundation
Linkedin: linkedin.com/company/livelyhealthfoundation
Instagram: instagram.com/livelyhealthfoundation
Twitter: twitter.com/livelyhealthapp

Natural Healing: It’s Time to Ditch Over-the-Counter Painkillers

Natural Healing: It’s Time to Ditch Over-the-Counter Painkillers

August 6, 2021

 

JoannaM-headshot-700x834.jpg

 

Joanna Matson-Tandberg, Founder of ZV Botanicals that provides Ayurvedic herbs and CBD as a remedy for pain relief joins eHealth Radio and the Pain Management Channel.


Listen to interview with host Eric Michaels and guest Joanna Matson-Tandberg discuss the following:

  1. What brought you to Ayurveda as a healing modality and a career?
  2. Why did you decide to become a Cannabis Clinician and work with cannabis?
  3. What inspired you to launch a CBD company?
  4. Would you do it again?
  5. What is your intention moving forward with ZV Botanicals?

It’s a common scenario. You try your best to relieve chronic pain only to be affected by other side effects. The numbers are alarming at how many people get addicted to pain meds or have other adverse reactions. There is a natural approach that leaves you with the peace of mind that nothing dangerous is entering your body.

Pain sufferers are turning to ZV Botanicals as a source of natural CBD healing and immediate relief with no side effects. CBD salves, for instance, are absorbed in the body quickly and are all-natural. If you are a runner, for instance, you can find comfort in pain relief that supports heart health and your musculoskeletal, helping the regeneration of tissue.

ZV Botanicals blends Ayurvedic herbs and CBD to create a brand that is leading the way in natural healing with organic and wild-harvested ingredients harnessing the goodness of nature to treat the whole body.

For Joanna Matson-Tandberg, founder of ZV Botanicals, nature proved to be healing for herself and her family, so much so that she cultivated a brand dedicated to providing Ayurvedic herbs and CBD as a remedy for pain relief. Her brand helps people live their best lives, naturally.

 

ZVBNewsletterHeader2.png

 

Website: https://zvbotanicals.com

Social Media Links:
Facebook: facebook.com/zvbotanicals 
Instagram: instagram.com/zvbotanicals


The beliefs, views, ideas, thoughts and opinions expressed on any program are those of the persons appearing on the program and do not necessarily reflect the views and opinions of the eHealth Radio Network.

The Future of Keeping Your Hands & Home Clean Without Harmful Chemicals

The Future of Keeping Your Hands & Home Clean Without Harmful Chemicals

July 31, 2021

 

CY9A3089-Edit-2_Bust_1120X1214.jpeg

 

David Weaver, the CEO of Aphex BioCleanse Systems, a sanitization solutions company focused on the development and distribution of non-toxic and water-based sanitization and disinfection products trademarked as Hy-IQ® Water joins eHealth Radio and the COVID-19 Information and Health News Channels.


Listen to interview with host Eric Michaels and guest David Weaver discuss the following:

  1. How has cleaning and sanitization changed because of the COVID-19 pandemic?
  2. Your company has created a cleaning substance called Hy-IQ Water. What is that and what does it do?
  3. Why is Hy-IQ water better than alcohol-based hand sanitizers? Is it more effective?
  4. What kind of studies have you done on Hy-IQ Water to make sure it works?
  5. What would you say to someone who says that you need alcohol to kill germs?

SUMMARY: You don't need alcohol or chlorine to keep clean -- Hy-IQ Water is safer for humans AND the environment


Aphex BioCleanse Systems CEO David Weaver holds over 40 years of experience in engineering and design and is responsible for the creation of much of Aphex’s proprietary formulas. Previously, he spent over two decades as an optical engineer for Eastman Kodak, where he earned a name for himself by streamlining the company’s technology and operations, training its team around the world and innovating for the photography industry.

Following his role with Eastman Kodak, Weaver went on to found his own digital camera company, where he led the company to sell over $100 million within the first year through his innovations. He also helped Motorola launch the first-ever camera phone.

At Aphex, Weaver has spearheaded the creation of seven unique sanitization products that all use hydrogen-based cleaning technology to help keep people, places, pets, and products free of pathogens and our environment safe.

 

Hy-IQ_Registered_TM_Final_091024_18w1sy.jpg

Website: https://aphexus.com

Social Media Links:
Facebook: facebook.com/AphexBioCleanseSystems
Twitter: twitter.com/AphexSystems

July 28 is World Hepatitis Day: The Role of FibroScan to Cure HCV Among Veterans

July 28 is World Hepatitis Day: The Role of FibroScan to Cure HCV Among Veterans

July 28, 2021

 

Dustin_Lee983x5.png

 

Dustin Lee, Owner and President of Fidelis Sustainability Distribution, LLC, USMC scout sniper veteran and principal joins eHealth Radio and the Health News and Technology Channels to discuss the role FibroScan technology has played in curing hepatitis C virus (HCV) among the Department of Veterans Affairs (VA).


Listen to interview with host Eric Michaels and guest Dustin Lee discuss the following:

  1. What are the challenges of treating liver disease among veterans?
  2. What is the connection between hepatitis C virus (HCV) and nonalcoholic fatty liver disease (NAFLD)?
  3. How did the VA eradicate HCV among veterans?
  4. Why is FibroScan the VA’s liver assessment tool of choice, and how many VA Hospitals have purchased FibroScan?
  5. What are the benefits of FibroScan for physicians treating veterans?

Fidelis, LLC is a certified Service-Disabled Veteran Owned Small Business as well as a U.S. Small Business Administration certified Small Disadvantaged Business (8(a)) company. Fidelis provides a wide variety of services for the Federal, State, and Local government nationwide as well as overseas.

Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 2,500 peer-reviewed publications and examinations are covered by Medicare, Medicaid and many insurance plans.

logo_echosens_gradient6xp78.png

Website: https://echosens.com

Social Media Links:
Facebook: facebook.com/fibroscan.echosens 
Linkedin: linkedin.com/company/echosens 
Youtube: youtube.com/user/EchosensTV
Twitter: twitter.com/Echosens

Douglas Dieterich, M.D., discusses role of FibroScan in the diagnoses of chronic liver disease

Douglas Dieterich, M.D., discusses role of FibroScan in the diagnoses of chronic liver disease

July 22, 2021

 

Douglas_Dieterich6b6hd.png

 

Douglas Dieterich, M.D., director of the Institute for Liver Medicine, Mount Sinai Health System, and professor of medicine for the Division of Liver Disease, Icahn School of Medicine at Mount Sinai joins eHealth Radio and the Health News and Technology Channels to discuss noninvasive liver screening to halt the progression of liver disease.


Listen to interview with host Eric Michaels and guest Dr. Douglas Dieterich discuss the following:

  1. Please share with us the importance of ongoing assessment of liver stiffness and fat as part of a liver health assessment?
  2. What role does FibroScan play in the diagnoses of chronic liver diseases and cirrhosis?
  3. What is the risk of hepatocellular carcinoma (HCC) in people with long-term liver diseases, and if the liver is scarred by infection with hepatitis B or hepatitis C?
  4. Tell us more about the use of FibroScan in hospital settings to improve outcomes and reduce costs in the assessment of liver disease.
  5. Where do you see this going in terms of management and improving outcomes?

Dr. Douglas Dieterich is currently Professor of Medicine in the Division of Liver Diseases and also Director of Continuing Medical Education in the Department of Medicine at Mount Sinai School of Medicine, New York, NY.

He has a triple appointment in the divisions of Liver Disease, Gastroenterology, and Infectious Diseases.

Douglas T. Dieterich graduated from Yale University in New Haven, CT and received his Doctorate of Medicine from New York University of Medicine in NY. He completed his internship and residency in Internal Medicine at the Bellevue Hospital Center in New York, NY where he was also a fellow in the Division of Gastroenterology. He became Clinical Assistant Professor of medicine and then a Clinical Professor of Medicine, both at the New York University. He remains as an Adjunct Clinical Professor of Medicine at New York University School of Medicine.

Dr. Dieterich is an investigator for many ongoing clinical trials evaluating the safety and efficacy of new antiviral treatments for chronic hepatitis B & C.

Dr. Dieterich is a member of many professional societies and is a fellow of both the American College of Physicians and the American College of Gastroenterology. He has served on several committees of the AIDS Clinical Trials Group at the National Institutes of Health (NIH), including the Steering Committee of the Opportunistic Infections Core Committee and the Cytomegalovirus (CMV) Committee. He was Chair and Co-Chair, respectively, of the Enteric Parasites Committee and the Protozoan Committee. He also served on the NIH Study Sections for CMV and cryptosporidiosis.

Widely published, Dr. Dieterich is the author of numerous journal articles, abstracts and book chapters on viral hepatitis and AIDS associated infections of the gastrointestinal tract and liver.

logo_echosens_gradient6xp78.png

Website: https://echosens.com

Social Media Links:
Facebook: facebook.com/fibroscan.echosens 
Linkedin: linkedin.com/company/echosens 
Youtube: youtube.com/user/EchosensTV
Twitter: twitter.com/Echosens

Plus Therapeutics: Gliblastoma, Rhenium NanoLiposome, and Harnessing the Power of Radiation Therapy

Plus Therapeutics: Gliblastoma, Rhenium NanoLiposome, and Harnessing the Power of Radiation Therapy

July 15, 2021

 

Dr_Mark_Hedrick8ef5z.png

 

Dr. Marc Hedrick, President and CEO at Plus Therapeutics which is a clinical-stage pharmaceutical company focused on making a positive impact on patients’ lives and adding value to the healthcare system joins eHealth Radio and the Cancer Information and Health News Channels.


Listen to interview with host Eric Michaels and guest Dr. Marc Hedrick discuss the following:

  1. What is Plus Therapeutics, and what is its mission?
  2. Tell us about your background and what brought you to Plus Therapeutics?
  3. What is Rhenium NanoLiposome (RNL™) and how is it delivered to cancerous brain tumors?
  4. How could RNL help advance current treatment options for GBM and why is this important for patients?
  5. Do you think most people understand radiation and its potential benefits as a cancer therapy?
  6. What do you think is the most common misconception that people hold about radiation as a cancer treatment?
  7. What’s next Plus Therapeutics? Is Plus developing other investigational candidates as part of its broader pipeline?

Dr. Marc Hedrick is the President and CEO at PLUS THERAPEUTICS, Inc. Previously, Dr. Hedrick served in a number of executive leadership roles including President, CEO, and Director at Cytori Therapeutics, Inc., and President and CEO of StemSource, Inc. Dr. Hedrick is a trained general, vascular, and plastic surgeon and former Associate Professor of Surgery and Pediatrics at the University of California, Los Angeles (UCLA). Dr. Hedrick also served as Co-Director of the Laboratory of Regenerative Bioengineering and Repair at UCLA. Dr. Hedrick obtained his MD from the University of Texas Southwestern Medical School, Dallas and a MBA from The Anderson School at UCLA in 2005.

 

PLUS-06-e1559589501420.jpg

 

Website: plustherapeutics.com

Social Media Links:
Facebook: facebook.com/plustherapeutics 
Instagram: instagram.com/plustherapeutics 
Twitter: twitter.com/plustxinc
Linkedin: linkedin.com/company/plustherapeutics

Talking With One of America’s Top Facial Cosmetic Surgeons!

Talking With One of America’s Top Facial Cosmetic Surgeons!

July 10, 2021

 

Dr_Daria_Hamrahb3j82.png

 

Dr. Daria Hamrah, a top Double Board Certified Oral and Maxillofacial / Facial Cosmetic Surgeon in the US joins eHealth Radio and the Beauty and Health News & Plastic Surgery Information Channels.


Listen to interview with host Eric Michaels and guest Dr. Daria Hamrah discuss the following:

  1. What procedures have people been getting most during the pandemic?
  2. What new types of technology have you been using these days that is really changing the game?
  3. With your charity foundation, tell us about it and why is providing services to kids in Colombia so important to you?
  4. What tips can you give people when selecting a facial cosmetic surgeon?
  5. What else do you have planned for 2021?

Dr. Daria Hamrah is a top double Board Certified oral and maxillofacial / facial cosmetic surgeon in America. When he isn't performing surgeries, Dr. Hamrah is also the co-founder of a non-profit called “The Alegria Foundation”, which helps children with cleft lip and palate and facial deformities; Dr. Hamrah travels to Colombia yearly and donates his time performing cleft lip procedures for the children there.


Website: https://novasurgicare.com

Social Media Links:
Facebook: facebook.com/NOVASURGICARE
Instagram: instagram.com/drhamrah
Twitter: twitter.com/realdrhamrah
YouTube: youtube.com/user/drhamrah

Echosens CEO Discusses How Company Helps Fight Liver Disease Epidemic

Echosens CEO Discusses How Company Helps Fight Liver Disease Epidemic

July 5, 2021

 

Jon_Gingrich_2021ah5vj.png

 

Jon Gingrich, the CEO of Echosens North America, a high-technology company offering the FibroScan family of products joins eHealth Radio and the Health News & Technology Channels.


Listen to interview with host Eric Michaels and guest Jon Gingrich discuss the following:

  1. Please share with us the ongoing need for liver health assessment – and why the detection of fatty liver disease remains such a pressing challenge for Americans.

  2. Please tell our audiences about the 2021 Echosens corporate initiatives and its focus on halting the progression of non-alcoholic fatty liver disease (NAFLD), fibrosis and cirrhosis. Describe new goals and objectives for building on the progress that Echosens has made in 2020.
  3. Explain how Echosens plans to further expand the use of FibroScan technology in healthcare systems across America.

  4. Can you describe specific programs and services to help educate specialists on the role of FibroScan?

  5. How is Echosens helping payers and employers to understand the value of FibroScan?

  6. Tell us about Echosens’ FAST score implementation and what successes you are seeing as a result of its use.

  7. Explain how the COVID-19 pandemic has highlighted opportunities for Echosens to solve new problems, and support innovations that advance preventive care, address critical health care needs and improve outcomes for more Americans.
  8. What is Echosens’ focus to continue bringing this awareness of NAFLD diagnosis and treatment in a post-pandemic world?

About Jon Gingrich, CEO, Echosens North America

With more than 20 years of global medical device and health care sales, marketing and general management experience at AxoGen, Inc., Hologic, Inc., Boston Scientific Corporation and Unilever, N.V, Gingrich now leads the development and execution of the Echosens U.S. strategy for expanding the utilization of FibroScan® technology in the assessment of chronic liver disease. As a member of the broader global executive leadership team, he works to implement the Company’s transformation plan and shape the future of Echosens.

About Echosens

Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 2,500 peer-reviewed publications and examinations are covered by Medicare, Medicaid and many insurance plans.

logo_echosens_gradient6xp78.png

Website: https://echosens.com

Social Media Links:
Facebook: facebook.com/fibroscan.echosens 
Linkedin: linkedin.com/company/echosens 
Youtube: youtube.com/user/EchosensTV

Community is Key:  The final push for herd immunity

Community is Key: The final push for herd immunity

July 1, 2021

 

Alexis_Hunter98ce2.jpeg

 

Alexis Hunter, Community Liaison for Wilmington Health, a physician-owned primary care and multi-specialty medical practice serving Wilmington and the Southeastern North Carolina area joins eHealth Radio and the COVID-19, Health Care and Health News Channels.


Listen to interview with host Eric Michaels & guest Alexis Hunter discuss the following:

  1. What current trends are we seeing with vaccinations across the U.S.?
  2. What has changed over the past six months that the vaccine has been available?
  3. How are rural/lower-income areas effected?
  4. Has one demographic been more hesitant than another?
  5. How are you continuing to get the word out in your community?

Alexis joined Wilmington Health, one of the largest independent, multi-specialty practices in North Carolina, in April 2020. Recruited as the first dedicated outreach employee for the organization, she focuses on building relationships with organizations and individuals in southeastern North Carolina. Alexis dedicates herself to Wilmington Health’s vision of aspiring to be the most trusted partner in healthcare, transforming the delivery system, and continually developing collaborative and innovative solutions that demonstrate quality, reduce the cost of care, and improve the patient experience.

Before joining Wilmington Health, she worked in administration for a private mental health practice. She works closely with area employers to ensure employees have access to expert healthcare. She also collaborates with outside providers, so that patients in the community have access to the providers that can best suit their healthcare needs.

 

wilmington_health9ocxx.jpeg

 

Website: wilmingtonhealth.com

Social Media Links:
Facebook: facebook.com/wilmingtonhealth 
Instagram: @wilmhealth
LinkedIn: linkedin.com/company/wilmington-health-associates

Podbean App

Play this podcast on Podbean App